National Meeting Highlights from the American Pain Society 2013
Release Date: June 03, 2013
Expiration Date: June 03, 2014
Expected time to complete this activity as designed: 60 minutes
There are no fees for participating in or receiving credit for this online activity.
This educational initiative offers highlights from key sessions and posters presented at the American Pain Society meeting in 2013. Experts on pain management and addiction medicine will offer clinical perspectives on the challenges of managing chronic pain.
This activity is designed for physicians, pharmacists, physician assistants, nurses, and other health care professionals who have an interest in enhancing their clinical skills in pain management.
Upon completion of this educational activity, participants should be able to:
- Identify and evaluate therapeutic implications of new conference data from the American Pain Society 2013 meeting related to pain management
Pain Education – Jeffrey A. Gudin, MD with Paul Arnstein, RN, PhD
The First Buprenorphine Transdermal System – Jeffrey A. Gudin, MD
An Innovative, Case Based Inter-Professional Approach to Pain – Chris Herndon, PharmD, BCPS, CPE
Current Topics, Treatments, and Trends in the Use of Opioids in 2013: A Roundtable Discussion – Jeffrey A. Gudin, MD with Bill H. McCarberg, MD
Effect of Subcutaneous Methylnaltrexone on Patient-Reported Outcomes in Patients with Advanced Illness with Opioid-Induced Constipation – John Peppin, DO
Patient Perception of Change Following an Interdisciplinary Pain Management Program – Steven P. Stanos, DO
Improving Functional Status Among African Americans with Cancer Pain – April Hazard Vallerand, PhD, RN, FAAN
Instructions for Participation and Credit
This activity is eligible for credit through June 3, 2014. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.
Paul Arnstein, RN, PhD, FAAN
Clinical Nurse Specialist for Pain Relief
Massachusetts General Hospital
Dr. Paul Arnstein earned a doctorate in nursing from Boston College in Chestnut Hill, Massachusetts and completed research training fellowships from the National Institutes of Health. For over 30 years, he has helped thousands of patients in pain. His work with patients, professionals, and policymakers is driven by a desire to ensure that no patient lives or dies with needless pain due to unrealistic fears and mistaken beliefs about pain and its treatment. His research has been referenced in the popular media and supports the value of nurse-led interventions that help chronic pain patients think, feel, and do better.
Dr. Arnstein was a founder and first president of the New Hampshire Cancer Pain Initiative and has served as president of the New England Pain Association and the American Society for Pain Management Nursing (ASPMN). He presided over ASPMN at a time when pain management nursing emerged as a specialty within nursing. Dr. Arnstein helped develop the core curricula, exam, and certification preparation materials that have benefited over 1,000 nurses and the patients they serve. As a liaison to the Joint Commission, and an advisor to legislators through the Pain Care Forum, Dr. Arnstein has expanded nursing’s influence in promoting access to pain relievers and ensuring their safe use.
Dr. Arnstein has participated in the development and dissemination of several position papers to help reduce pain in vulnerable populations. He is a strong spokesperson for nursing’s contributions for interdisciplinary programs and clinical guidelines developed by the American Pain Society, American Pain Foundation, and the Agency for Healthcare Research and Quality. Dr. Arnstein is widely published and frequently speaks at local, regional, and national levels addressing topics that help improve the way pain is managed.
Jeffrey A. Gudin, MD
Pain Management Center
Englewood Hospital and Medical Center
Englewood, New Jersey
Dr. Jeffrey A. Gudin received his medical degree from Albany Medical College in Albany, New York. Following a transitional internship in surgery, medicine, and anesthesiology at St. Barnabas Medical Center in Livingston, New Jersey, he completed a residency in anesthesiology at Yale University School of Medicine. He continued his training with an extended postdoctoral fellowship in pain medicine at the Yale Center for Pain Management, where he was actively involved in research and teaching. He is currently director of the Pain Management Center at Englewood Hospital and Medical Center in New Jersey, an affiliate of the Mount Sinai School of Medicine. Dr. Gudin is board certified in pain medicine and anesthesiology, and is board eligible in addiction medicine.
An active speaker in the field of pain management, Dr. Gudin has been interviewed on various television news channels, including CBS, and other national news networks. Dr. Gudin has also been quoted in The New York Times and various regional newspapers in New Jersey and Connecticut. His clinical and research focus includes pain management, regional anesthesia, and preemptive analgesia, as well as increasing clinician awareness of pain assessment and management.
Chris Herndon, PharmD, BCPS, CPE
Southern Illinois University Edwardsville
Dr. Chris Herndon received his doctor of pharmacy degree from the St. Louis College of Pharmacy. He then completed a geriatric pharmacotherapy specialty residency at the University of New Mexico Health Sciences Center. He is currently an associate professor at Southern Illinois University Edwardsville.
Dr. Herndon is a certified pain educator, American Society of Pain Educators, and a pharmacotherapy specialist, Board of Pharmaceutical Specialties, and is also a member of the International Association for the Study of Pain, American Society of Pain Educators, American Pain Society, and a fellow, American Society of Health-System Pharmacists. He holds editorial board positions at Journal of Pain and Palliative Care Pharmacotherapy and Journal of Opioid Management, and is an ad hoc reviewer for several professional publications. He has lectured and published numerous manuscripts, book chapters and abstracts and his research interests focus on pain and palliative care.
Bill McCarberg, MD
Chronic Pain Management Program
San Diego, California
Dr. Bill McCarberg received his medical degree from the Northwestern University in Chicago, Illinois. He completed his internship and residency in family medicine at Highland Hospital, Rochester, New York. Dr. McCarberg is a founding member of the Chronic Pain Management Program at Kaiser Permanente, San Diego, California and is a voluntary assistant clinical professor at the University of California, San Diego.
Dr. McCarberg is a member of numerous professional societies including the American Academy of Family Physicians, the American Academy of Pain Medicine, and the International Association for the Study of Pain. He has also served on the Board of Directors of the American Pain Society, and is president and program chair of the Western Pain Society symposium committee. Dr. McCarberg currently serves as treasurer of the American Academy of Pain Medicine.
A frequent lecturer, Dr. McCarberg has also authored several journal articles on pain management and is a co-editor of the National Initiative on Pain Control newsletter. He is the recipient of the Elizabeth Narcessian Award for Outstanding Achievements in the Field of Pain Medicine from the American Pain Society, and the ASHPE Gold Award for Best How-To Article Series: Field Guide to Pain.
John F. Peppin, DO, FACP
Associate Medical Director
Hospice of the Bluegrass
Palliative Care Center of the Bluegrass
Dr. John Peppin completed his medical degree at the University of Osteopathic Medicine and Health Sciences, Des Moines, Iowa. He continued his postgraduate education with an internal medicine residency at the University of Wisconsin, Marshfield Clinic/St. Joseph’s Hospital. Dr. Peppin is currently associate medical director, Hospice of the Bluegrass and the Palliative Care Center of the Bluegrass, Lexington, Kentucky. He is also CEO, president and founder, Iowa Pain Management Clinic, Des Moines, Iowa.
Dr. Peppin is board certified by the American Board of Internal Medicine, American Board of Psychiatry and Neurology, American Board of Pain Medicine, and the American Board of Hospice and Palliative Care Medicine. Additionally, he is a certified Education in Palliative and End-of-Life Care (EPEC) trainer. He serves on numerous professional committees and is an editor and peer reviewer for numerous journals. Dr. Peppin has published articles in the fields of pain management, palliative care and bioethics, has edited numerous books, and has given numerous lectures at conferences on topics in pain and palliative medicine, bioethics, end-of-life care, and internal medicine.
Steven P. Stanos, DO
Center for Pain Management
Rehabilitation Institute of Chicago
Assistant Professor, Department of Physical Medicine and Rehabilitation
Northwestern University Medical School, Feinberg School of Medicine
Dr. Steven Stanos earned his doctor of osteopathy degree from Nova Southeastern University in Miami, Florida and went on to complete his internship at Chicago Osteopathic Hospitals and Medical Centers, Midwestern University, Chicago, Illinois. He completed both his residency and pain fellowship in the Department of Physical Medicine and Rehabilitation, Northwestern University Medical School, Rehabilitation Institute of Chicago (RIC), where he is currently an assistant professor. In addition, Dr. Stanos is the medical director at the RIC Center for Pain Management in Chicago.
Dr. Stanos is board certified by the American Board of Physical Medicine & Rehabilitation, as well as a diplomate of the American Board of Pain Medicine and the American Board of Physical Medicine and Rehabilitation, with subspecialty certification in pain. In addition, he is a member of numerous professional societies, including the American Academy of Pain Medicine, the American Pain Society, and the Midwest Pain Society, among others. Dr. Stanos has lectured and published numerous manuscripts, book chapters and abstracts on the treatment and management of pain.
April Hazard Vallerand, PhD, RN, FAAN
College of Nursing
Wayne State University
Dr. April Hazard Vallerand received her bachelor's degree in nursing from Mount St. Mary's College and her master of science degree in nursing from California State University. She received her PhD in nursing from the University of Pennsylvania and completed a three-year postdoctoral fellowship in psychosocial oncology at the University of Pennsylvania School of Nursing. She is currently an associate professor in the College of Nursing at Wayne State University, Detroit.
Dr. Vallerand is a fellow in the American Academy of Nursing and is the principal investigator on the study Improving Functional Status in African Americans with Cancer Pain, funded by the National Cancer Institute. She lectures nationally on the management of pain, and has published numerous articles on pain and pain control. She has also authored five books on pharmacology for nurses and other health care professionals, including Davis's Drug Guide for Nurses. Dr. Vallerand's research interests are focused on the improvement and maintenance of functional status in patients with chronic pain and the identification and reduction of pain-related disparities.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-13-354-H01-P. Knowledge-based CPE activity.
In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 13-354-318
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.
Dr. Paul Arnstein has disclosed no relevant financial relationships.
Dr. Jeffrey Gudin has received honoraria related to speakers’ bureau activities from Alere, Covidien, Endo Pharmaceuticals Inc., Johnson & Johnson Services, Inc., Purdue Pharma L.P., Salix Pharmaceuticals, Inc., and Teva Pharmaceuticals.
Dr. Chris Herndon has received consultant fees from Endo Pharmaceuticals, Incline, and Premier Research.
Dr. Bill McCarberg has received honoraria related to formal advisory activities for Insys Therapeutics, Iroko, Neurogesx, Pfizer, Salix, Sucampo, Teva Pharmaceuticals and Zogenix.
Dr. John Peppin has received honoraria related to speakers’ bureau activities from AIKO Biotechnology, Inc.; Ameritox; Eli Lilly and Company; Pfizer Inc.; Salix Pharmaceuticals, Inc.; Shionogi Inc.; Theravance, Inc.; and Trevena, Inc. He has received grant support related to research activities from AstraZeneca; NeurogesX; Pfizer; Shionogi; and Teva Pharmaceuticals.
Dr. Steven Stanos has received honoraria related to formal advisory activities and consultant fees from Endo Pharmaceuticals Inc., GlaxoSmithKline plc., Janssen Pharmaceuticals, Inc., myMatrixx, and Pfizer Inc.
Dr. April Vallerand has received honoraria related to speakers' bureau activities from Pfizer, Inc. and as a consultant from Teva Pharmaceuticals.
Planning Committee Disclosures
The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, has no relevant financial relationships.
Peer Reviewer Disclosure
In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Drs. Arnstein, Gudin, Herndon, McCarberg, Peppin, Stanos, and Vallerand have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.
Drs. Arnstein, Gudin, Herndon, McCarberg, Peppin, Stanos, and Vallerand have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.
MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at firstname.lastname@example.org.
Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Purdue Pharma L.P., Teva Pharmaceuticals, Covidien, Salix Pharmaceuticals, and Takeda Pharmaceuticals International, Inc.
©2013 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.